Fentanyl and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided Superficial Cervica… (NCT07057739) | Clinical Trial Compass
CompletedNot Applicable
Fentanyl and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided Superficial Cervical Plexus Block in Thyroid Surgeries
Egypt60 participantsStarted 2024-06-30
Plain-language summary
This study aimed to compare the analgesic efficacy between fentanyl and dexmedetomidine as adjuvants to bupivacaine in ultrasound-guided superficial cervical plexus block for thyroid surgeries.
Who can participate
Age range20 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient's approval.
* Aged 20-65 years
* American Society of Anesthesiologists (ASA) physical status I or II
* Undergoing thyroid surgery
* Euthyroid patients
Exclusion Criteria:
* Patient refusal.
* Age: \>65 and \<20 years.
* Allergy to Dexmedetomidine, local anesthetics, systemic opioids and any of the drugs included in the multimodal perioperative pain protocol.
* Patient with coagulation disorders.
* Chronic pain syndromes and patients with chronic opioid use are defined as use of regular daily doses of systemic narcotics for the past 6 months prior to the surgery.
* BMI of 35 kg/m2 or more.
* Physical Status: American Society of Anesthesiologists (ASA) III \& IV.
* Local infection or sepsis at the site of injection.